Literature DB >> 26244135

A pooled analysis of stereotactic ablative radiotherapy versus lobectomy for operable stage I non-small cell lung cancer: is failure to recruit patients into randomized trials also an answer to the research question?

Carsten Nieder1, Nicolaus H Andratschke1, Matthias Guckenberger1.   

Abstract

Entities:  

Year:  2015        PMID： 26244135      PMCID： PMC4499667          DOI： 10.3978/j.issn.2305-5839.2015.06.05

Source DB:  PubMed          Journal:  Ann Transl Med        ISSN： 2305-5839


× No keyword cloud information.
  16 in total

Review 1.  Extracranial stereotactic radiation delivery: expansion of technology beyond the brain.

Authors:  Robert Timmerman; Lech Papiez; Mohan Suntharalingam
Journal:  Technol Cancer Res Treat       Date:  2003-04

2.  LungTech, an EORTC Phase II trial of stereotactic body radiotherapy for centrally located lung tumours: a clinical perspective.

Authors:  S Adebahr; S Collette; E Shash; M Lambrecht; C Le Pechoux; C Faivre-Finn; D De Ruysscher; H Peulen; J Belderbos; R Dziadziuszko; C Fink; M Guckenberger; C Hurkmans; U Nestle
Journal:  Br J Radiol       Date:  2015-04-15       Impact factor: 3.039

Review 3.  Low-dose computed tomographic screening for lung cancer.

Authors:  Jared D Christensen; Caroline Chiles
Journal:  Clin Chest Med       Date:  2015-04-11       Impact factor: 2.878

4.  Dose-response relationship with clinical outcome for lung stereotactic body radiotherapy (SBRT) delivered via online image guidance.

Authors:  Larry Kestin; Inga Grills; Matthias Guckenberger; Jose Belderbos; Andrew J Hope; Maria Werner-Wasik; Jan-Jakob Sonke; Jean-Pierre Bissonnette; Ying Xiao; Di Yan
Journal:  Radiother Oncol       Date:  2014-03-11       Impact factor: 6.280

Review 5.  Radical radiotherapy for stage I/II non-small cell lung cancer in patients not sufficiently fit for or declining surgery (medically inoperable).

Authors:  N P Rowell; C J Williams
Journal:  Cochrane Database Syst Rev       Date:  2001

Review 6.  Is there an oligometastatic state in non-small cell lung cancer? A systematic review of the literature.

Authors:  Allison Ashworth; George Rodrigues; Gabriel Boldt; David Palma
Journal:  Lung Cancer       Date:  2013-08-20       Impact factor: 5.705

7.  Stereotactic ablative radiotherapy versus lobectomy for operable stage I non-small-cell lung cancer: a pooled analysis of two randomised trials.

Authors:  Joe Y Chang; Suresh Senan; Marinus A Paul; Reza J Mehran; Alexander V Louie; Peter Balter; Harry J M Groen; Stephen E McRae; Joachim Widder; Lei Feng; Ben E E M van den Borne; Mark F Munsell; Coen Hurkmans; Donald A Berry; Erik van Werkhoven; John J Kresl; Anne-Marie Dingemans; Omar Dawood; Cornelis J A Haasbeek; Larry S Carpenter; Katrien De Jaeger; Ritsuko Komaki; Ben J Slotman; Egbert F Smit; Jack A Roth
Journal:  Lancet Oncol       Date:  2015-05-13       Impact factor: 41.316

8.  The IASLC Lung Cancer Staging Project: proposals for the revision of the TNM stage groupings in the forthcoming (seventh) edition of the TNM Classification of malignant tumours.

Authors:  Peter Goldstraw; John Crowley; Kari Chansky; Dorothy J Giroux; Patti A Groome; Ramon Rami-Porta; Pieter E Postmus; Valerie Rusch; Leslie Sobin
Journal:  J Thorac Oncol       Date:  2007-08       Impact factor: 15.609

9.  Stereotactic high dose fraction radiation therapy of extracranial tumors using an accelerator. Clinical experience of the first thirty-one patients.

Authors:  H Blomgren; I Lax; I Näslund; R Svanström
Journal:  Acta Oncol       Date:  1995       Impact factor: 4.089

10.  Radical treatment of non-small-cell lung cancer patients with synchronous oligometastases: long-term results of a prospective phase II trial (Nct01282450).

Authors:  Dirk De Ruysscher; Rinus Wanders; Angela van Baardwijk; Anne-Marie C Dingemans; Bart Reymen; Ruud Houben; Gerben Bootsma; Cordula Pitz; Linda van Eijsden; Wiel Geraedts; Brigitta G Baumert; Philippe Lambin
Journal:  J Thorac Oncol       Date:  2012-10       Impact factor: 15.609
View more
  2 in total

1.  Reirradiation of recurrent node-positive non-small cell lung cancer after previous stereotactic radiotherapy for stage I disease : A multi-institutional treatment recommendation.

Authors:  Carsten Nieder; Dirk De Ruysscher; Laurie E Gaspar; Matthias Guckenberger; Minesh P Mehta; Patrick Cheung; Arjun Sahgal
Journal:  Strahlenther Onkol       Date:  2017-04-19       Impact factor: 3.621

2.  Helping patients with lung cancer choose between surgery or stereotactic body radiotherapy: the importance of the patient experience.

Authors:  Michael MacManus; Richard De Abreu Lourenco; Fiona Hegi-Johnson
Journal:  J Thorac Dis       Date:  2019-11       Impact factor: 2.895
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.